MAIN INDICATIONS:
It is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
DOSAGE AND USES:
Each unit-dose vials contain 500 mcg ipratropium bromide anhydrous in 2.0 ml normal saline. Ipratropium bromide inhalation solution can be mixed in the nebulizer with albuterol if used within one hour.
